Key result
Leg fat mass was associated with a reduced risk of transition from first cardiometabolic disease to death.
Why the study?
The study aimed to investigate the association of whole body and regional fat mass with cardiometabolic disease trajectories.
How does whole body and regional fat mass associate with the trajectory of cardiometabolic diseases and mortality?
Cohort (n=423,966)
How does whole body and regional fat mass associate with the trajectory of cardiometabolic diseases and mortality?
Regional fat distribution has divergent effects on cardiometabolic disease trajectories, with upper body fat increasing mortality risk and leg fat being protective.
Answers are grounded in this paper and cite their sources.
Leg fat's mortality association after cardiometabolic disease onset warrants no practice change; hypothesis-generating for regional adiposity research.
OBJECTIVE: This study aimed to investigate the association of whole body/regional fat mass (FM) with cardiometabolic disease (CMD) trajectory. METHODS: We conducted a prospective analysis using the UK Biobank. The FM index (FMI), a surrogate for whole body FM, and regional FM (i.e., arm, leg, and trunk) were examined as exposures. A nonlinear multistate framework was used to evaluate the association between whole/regional FM and CMD trajectory. RESULTS: Among the 423,966 participants (mean age 56.1 [SD 8.10] years, 43.9% men) with a median follow-up of 13.5 years, varied associations were identified between whole/regional FM and transitions in the CMD trajectory. Upper body FM (i.e., arm and trunk) exhibited significant positive J-shaped associations in the transitions from first CMD (FCMD) or cardiometabolic multimorbidity to death; however, FMI and leg FM demonstrated L-shaped associations. Leg FM played a beneficial role in the transition from FCMD to death, with a hazard ratio of 0.950 (95% CI: 0.931-0.968) per 1 kg. CONCLUSIONS: Body fat composition and distribution revealed various associations with CMD trajectory, highlighting their clinical importance. Upper body FM among those participants with FCMD or cardiometabolic multimorbidity demonstrated positive J-shaped associations toward death, providing no evidence of the "obesity paradox."
No takes yet. Share an insight, caveat, or question.
Xu et al. (2024) conducted a cohort in Cardiometabolic disease (n=423,966). Whole body and regional fat mass was evaluated on Transition from first cardiometabolic disease to death (HR 0.950, 95% CI 0.931-0.968). Leg fat mass was associated with a reduced risk of transition from first cardiometabolic disease to death.
Synapse has enriched 10 related papers. Consider them for comparative context: